Teva Pharmaceutical Industries (TEVA) EBIT Margin (2009 - 2026)
Teva Pharmaceutical Industries' EBIT Margin was -5.58% in Q2 2026, down 16.47 percentage points from 10.90% a year earlier and down 21.95 percentage points from the prior quarter.
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) EBIT Margin (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Teva Pharmaceutical Industries' EBIT Margin was 9.26% through Jun 30, 2026, up 3.88 percentage points year-over-year; for FY2025, it came in at 12.50%, up 14.33 percentage points from FY2024.
- EBIT Margin shows a five-year change of +33.94 percentage points (FY2020 to FY2025).
- In earlier years, EBIT Margin was -1.83% in FY2024 (-4.56 pp), 2.73% in FY2023 (+17.45 pp), -14.72% in FY2022 (-25.53 pp) and 10.81% in FY2021 (+32.25 pp).
- The Q2 2026 figure marks the lowest quarterly EBIT Margin since Q1 2024.
- Compared with a year earlier, EBIT Margin was higher in five of the last eight quarters, with an average year-over-year change of +2.10 percentage points.
- The best year-over-year quarter for EBIT Margin over five years was Q3 2021 (a gain of 125.18 percentage points); the worst was Q2 2022 (a drop of 40.43 percentage points).
- Per Business Quant data, TEVA's EBIT Margin in the three quarters before Q2 2026 was 16.37% (Q1 2026), 6.37% (Q4 2025) and 19.69% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Teva Pharmaceutical Industries | 45.31 Bn | 32.16 Bn | 2.15 Bn | -5.58% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5.58% |
| Mar 31, 2026 | 16.37% |
| Dec 31, 2025 | 6.37% |
| Sep 30, 2025 | 19.69% |
| Jun 30, 2025 | 10.90% |
| Mar 31, 2025 | 13.34% |
| Dec 31, 2024 | -0.69% |
| Sep 30, 2024 | -1.18% |
| Jun 30, 2024 | -0.12% |
| Mar 31, 2024 | -5.71% |
| Dec 31, 2023 | 16.96% |
| Sep 30, 2023 | 8.94% |
| Jun 30, 2023 | -16.86% |
| Mar 31, 2023 | -0.36% |
| Dec 31, 2022 | -24.20% |
| Sep 30, 2022 | 11.79% |
| Jun 30, 2022 | -25.54% |
| Mar 31, 2022 | -19.48% |
| Dec 31, 2021 | 1.90% |
| Sep 30, 2021 | 16.03% |
API Access
Teva Pharmaceutical Industries EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=TEVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "TEVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=TEVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();